Reduced viscosity Barley β-Glucan versus placebo: a randomized controlled trial of the effects on insulin sensitivity for individuals at risk for diabetes mellitus
2011

Effects of Barley β-Glucan on Insulin Sensitivity

Sample size: 50 publication Evidence: moderate

Author Information

Author(s): Harold Bays, Joy L. Frestedt, Margie Bell, Carolyn Williams, Lore Kolberg, Wade Schmelzer, James W. Anderson

Primary Institution: Louisville Metabolic & Atherosclerosis Research Center

Hypothesis

Does reduced viscosity barley β-glucan improve insulin sensitivity in individuals at risk for diabetes mellitus?

Conclusion

The study found that consuming 6 g/d of barley β-glucan for 12 weeks may improve insulin sensitivity in hyperglycemic individuals without prior diabetes diagnosis.

Supporting Evidence

  • 3 g/d of BBG significantly reduced glucose iAUC during OGTT.
  • 6 g/d of BBG significantly reduced fasting insulin and HOMA-IR.
  • Subjects maintained body weight throughout the study.

Takeaway

Drinking a special barley drink can help people who are at risk for diabetes to use insulin better, which is good for their health.

Methodology

This was a randomized, double-blind, placebo-controlled trial with 50 healthy subjects who consumed either a placebo or barley β-glucan for 12 weeks.

Potential Biases

Potential biases related to self-reported dietary compliance and the small sample size.

Limitations

The sample size was relatively small, and the study duration may not capture long-term effects.

Participant Demographics

68% women, mean age 56 years, BMI 32 kg/m2, predominantly white (88%) and 12% African American.

Statistical Information

P-Value

0.008

Statistical Significance

p<0.05

Digital Object Identifier (DOI)

10.1186/1743-7075-8-58

Want to read the original?

Access the complete publication on the publisher's website

View Original Publication